|4Dec 16, 9:29 AM ET

Fedeli Fabiana 4

4 · RELMADA THERAPEUTICS, INC. · Filed Dec 16, 2025

Insider Transaction Report

Form 4
Period: 2025-12-12
Transactions
  • Award

    Stock Appreciation Rights

    2025-12-12+164,000164,000 total
    Exercise: $4.06From: 2026-03-12Exp: 2035-12-12Common Stock (164,000 underlying)
Footnotes (1)
  • [F1]The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.

Documents

1 file
  • 4
    ownership.xmlPrimary